300,000-square-foot facility adds 300 jobs and expands domestic production to support Pharmaceutical device innovation.
RICHFIELD, Wis. (February 19, 2026) –MGS, a leading healthcare contract development and manufacturing organization (CDMO), is proud to introduce its newest world-class manufacturing facility in Richfield, Wisconsin. A major milestone in its ongoing mission to accelerate innovations that improve lives, this 300,000-square-foot state-of-the-art operation was developed to support a global Pharmaceutical partner’s growing drug delivery platform.
Central to the site’s advanced capabilities is 140,000-square-feet of Class 8 cleanrooms designed for high-performance manufacturing, automation and assembly of complex Pharma drug delivery devices. Built to meet growing demand for faster scale-up and high-volume manufacturing, the site exemplifies how vertical integration and close customer alignment accelerate development.
In just 22 months from initial conversations to shipped parts, MGS transformed vision into reality. The result is a highly automated environment capable of producing hundreds of millions of sub-assemblies each year. Phase one of the build includes more than 100 injection molding machines, custom automation technology and high-efficiency automated assembly lines, engineered for scalability, quality and precision. Phase two builds on that foundation, doubling production capacity to support long-term product line growth.
“From day one, every decision was guided by our customer’s needs and the patients they serve,” said Bob Bordignon, senior vice president of sales & marketing at MGS. “This facility is proof of what’s possible when aligned expertise and a shared vision come together to accelerate life-changing therapies. Our agile structure and financial strength enabled the speed, investment and coordination required to bring this complex project to life on an ambitious timeline.”
The Richfield expansion brings MGS’ global footprint to 12 facilities, advancing its position as a vertically integrated partner to leading healthcare innovators. With capabilities spanning early-stage design and development, advanced tooling, custom automation, precision medical manufacturing and assembly, MGS serves as a single source across North America and Europe. These end-to-end services are reinforced by deep regulatory expertise and a highly skilled team, ensuring speed, compliance and confidence throughout the product lifecycle.
Building a Specialized Workforce for Advanced Pharmaceutical Device Manufacturing
The Richfield facility marks a strategic investment in both infrastructure and talent, and a significant boost for the local economy. The site will create 300 new jobs across engineering, production, automation, quality and mold maintenance, expanding access to high-quality careers in advanced manufacturing. Newly created roles will be open to both skilled professionals and those new to the industry, with full staffing anticipated by early 2027.
“MGS Richfield represents more than a new facility. It’s about people, innovation and long-term impact,” said Monica MacDonald, senior vice president of human resources at MGS. “We’re proud to support Richfield and the surrounding community by creating hundreds of jobs for seasoned manufacturers and those just starting their careers. This investment reflects our commitment to developing local talent, advancing critical technologies and creating strong career pathways that offer growth and opportunity in the communities we operate.”
In-demand roles include:
- Automation attendants and technicians
- Cell leads – plastic injection molding
- Maintenance technicians
- Manufacturing associates
- Metrology engineers
- Process engineers
- Mold maintenance leads and technicians
To meet workforce needs and increase flexibility, MGS Richfield operates on a unique rotating schedule that supports a range of employee preferences. All new hires receive hands-on training, creating long-term career paths and opportunities for continued growth.
Team members work at the intersection of advanced manufacturing technologies and globally recognized quality standards. It’s an environment where precision is critical and every role helps deliver breakthrough therapies to patients worldwide.
Learn more about MGS and its global end-to-end solutions at mgsmfg.com.
About MGS
MGS is a global contract development and manufacturing organization (CDMO) that helps healthcare innovators bridge the gap between imagination and realization. For leading Pharmaceutical, Diagnostic and MedTech companies, MGS accelerates the delivery of transformative solutions by combining robust, vertically integrated capabilities with the agility and focus of a true partner. From first sketch to final solution, the MGS team brings deep expertise, advanced technology and a collaborative mindset to every stage of the development lifecycle. With 12 locations across North America and Europe, MGS empowers customers to reduce risk, move faster and improve lives around the world. Learn more at mgsmfg.com.
